D. KARÇAALTINCABA Et Al. , "GDM prevalence after universal screening by 2hr OGTT 75 g evaluated by ADA 2013 criteria," 15th World Congress of Fetal Medicine,Mallorca İspanya. , 2016
KARÇAALTINCABA, D. Et Al. 2016. GDM prevalence after universal screening by 2hr OGTT 75 g evaluated by ADA 2013 criteria. 15th World Congress of Fetal Medicine,Mallorca İspanya. .
KARÇAALTINCABA, D., öcal, n., ALTUĞ İNAN, M., & BAYRAM, M., (2016). GDM prevalence after universal screening by 2hr OGTT 75 g evaluated by ADA 2013 criteria . 15th World Congress of Fetal Medicine,Mallorca İspanya.
KARÇAALTINCABA, DENİZ Et Al. "GDM prevalence after universal screening by 2hr OGTT 75 g evaluated by ADA 2013 criteria," 15th World Congress of Fetal Medicine,Mallorca İspanya., 2016
KARÇAALTINCABA, DENİZ Et Al. "GDM prevalence after universal screening by 2hr OGTT 75 g evaluated by ADA 2013 criteria." 15th World Congress of Fetal Medicine,Mallorca İspanya. , 2016
KARÇAALTINCABA, D. Et Al. (2016) . "GDM prevalence after universal screening by 2hr OGTT 75 g evaluated by ADA 2013 criteria." 15th World Congress of Fetal Medicine,Mallorca İspanya. .
@conferencepaper{conferencepaper, author={DENİZ KARÇAALTINCABA Et Al. }, title={GDM prevalence after universal screening by 2hr OGTT 75 g evaluated by ADA 2013 criteria}, congress name={15th World Congress of Fetal Medicine,Mallorca İspanya.}, city={}, country={}, year={2016}}